Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 5000237142

Medchemexpress LLC 3-methoxy-N-[4-(4-methoxyphenyl)-1,3-thiazol-2-yl]-4-(2-morpholin-4-yl-2-oxoethoxy)benzamide | 781628-99-7 | 98.0% | 483.54 g/mol | C24H25N3O6S | 10MG
SDP

Supplier:  Medchemexpress LLC HY12441810MG

Encompass_Preferred

SBI-477 is a small-molecule chemical probe that stimulates insulin signaling by deactivating the transcription factor MondoA, resulting in reduced expression of insulin-pathway suppressors and coordinated inhibition of triacylglyceride synthesis while enhancing basal glucose uptake in human skeletal myocytes.

  • Deactivates MondoA to stimulate insulin signaling.
  • Reduces TXNIP and ARRDC4 expression.
  • Inhibits triacylglyceride synthesis and increases basal glucose uptake.
  • Provided as a solid powder, supplied in a 10 mg package.
  • High purity: 98.0%.
  • Recommended storage: powder at -20°C (long-term) or 4°C (shorter term).

Catalog No. 50-002-37142


May include imposed supplier surcharges.
Only null left
Add to Cart

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.